The WACC of Revance Therapeutics Inc (RVNC) is 8.2%.
| Range | Selected | |
| Cost of equity | 6.40% - 11.30% | 8.85% |
| Tax rate | 0.10% - 0.10% | 0.10% |
| Cost of debt | 7.00% - 7.00% | 7.00% |
| WACC | 6.6% - 9.7% | 8.2% |
| Category | Low | High |
| Long-term bond rate | 3.9% | 4.4% |
| Equity market risk premium | 4.6% | 5.6% |
| Adjusted beta | 0.56 | 1.15 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 6.40% | 11.30% |
| Tax rate | 0.10% | 0.10% |
| Debt/Equity ratio | 0.63 | 0.63 |
| Cost of debt | 7.00% | 7.00% |
| After-tax WACC | 6.6% | 9.7% |
| Selected WACC | 8.2% | |